TRICIDA INC's ticker is TCDA and the CUSIP is 89610F101. A total of 118 filers reported holding TRICIDA INC in Q2 2022. The put-call ratio across all filers is 0.21 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2022 | $24,036 | -99.9% | 157,200 | -90.6% | 0.00% | -100.0% |
Q3 2022 | $17,578,000 | +108.1% | 1,677,242 | +92.3% | 0.07% | +94.4% |
Q2 2022 | $8,445,000 | -46.6% | 872,400 | -54.7% | 0.04% | -42.9% |
Q1 2022 | $15,825,000 | -49.5% | 1,925,185 | -41.3% | 0.06% | -49.6% |
Q4 2021 | $31,340,000 | +38.1% | 3,278,236 | -33.0% | 0.12% | +25.0% |
Q3 2021 | $22,689,000 | +9.1% | 4,889,949 | +1.6% | 0.10% | +7.5% |
Q2 2021 | $20,801,000 | +48.1% | 4,814,949 | +81.4% | 0.09% | +40.9% |
Q1 2021 | $14,042,000 | +28.2% | 2,654,361 | +119.6% | 0.07% | +17.9% |
Q3 2020 | $10,952,000 | -38.6% | 1,208,800 | +86.2% | 0.06% | -51.7% |
Q2 2020 | $17,836,000 | +3608.1% | 649,051 | +2867.9% | 0.12% | +2800.0% |
Q1 2020 | $481,000 | -91.5% | 21,869 | -85.5% | 0.00% | -86.7% |
Q4 2019 | $5,685,000 | -34.6% | 150,633 | -46.5% | 0.03% | -43.4% |
Q3 2019 | $8,697,000 | +220.8% | 281,724 | +310.1% | 0.05% | +278.6% |
Q2 2019 | $2,711,000 | -39.7% | 68,700 | -41.0% | 0.01% | -30.0% |
Q1 2019 | $4,494,000 | -36.5% | 116,360 | -61.2% | 0.02% | -42.9% |
Q4 2018 | $7,074,000 | – | 300,000 | – | 0.04% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
GREAT POINT PARTNERS LLC | 1,974,000 | $9,159,000 | 2.13% |
Lion Point Capital, LP | 1,826,729 | $8,476,000 | 1.59% |
Bleichroeder LP | 1,300,000 | $6,032,000 | 0.98% |
Orbimed Advisors | 9,614,280 | $44,610,000 | 0.49% |
STONEHILL CAPITAL MANAGEMENT LLC | 143,072 | $664,000 | 0.32% |
SABBY MANAGEMENT, LLC | 475,000 | $2,204,000 | 0.30% |
GSA CAPITAL PARTNERS LLP | 611,048 | $2,835,000 | 0.29% |
VR Adviser, LLC | 390,707 | $1,813,000 | 0.23% |
Ikarian Capital, LLC | 670,771 | $3,113,000 | 0.22% |
Point72 Asset Management, L.P. | 4,889,949 | $22,689,000 | 0.10% |